ESR1 and neoplasm: Only tumours of the luminal subgroups express the receptor alpha to estrogen (ERα); however, luminal A tumours express higher levels of ERα than luminal B tumours [1-3] and they are associated with less aggressive metastatic disease and longer disease-free survival [2].